Item 7.01 Regulation FD Disclosure.

On October 12, 2009, Synergy Pharmaceuticals, Inc. (the "Company") intends to present at the 17th Annual BioPartnering Europe Conference in London, United Kingdom. The Company's presentation is furnished as Exhibit 99.1 to this report.

The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, (the "Securities Act") except as expressly set forth in such filing.